2017 ISAKOS Biennial Congress ePoster #1907
Reduced Blood Loss with Low-Volume Topical Tranexamic Acid after RSA
Raul Barco, MD, PhD, FEBOT, Madrid SPAIN
Sara Morais, MD, Madrid, Madrid SPAIN
Samuel A. Antuna, MD, Langreo, Asturi SPAIN
FIBHULP, Madrid, Madrid, SPAIN
FDA Status Not Applicable
Summary
Reduced blood loss and drain output was observed after the use of low-volume topical tranexamic acid after RSA
Abstract
Background
Tranexamic acid (TXA) significantly decreases blood loss in hip and knee arthroplasty and has been shown to decrease also blood loss after total shoulder arthroplasty. The purpose of this study was to determine the decrease of blood loss after total shoulder arthroplasty using TXA
Methods
A total of 43 patients who underwent shoulder arthroplasty were prospectively randomized to receive 30 ml of TXA before deltopectoral closure or nothing. All patients received a postoperative drain. Blood loss was considered as drain output, transfusion requirements and change in hemoglobin levels were recorded. All complications were recorded.
Results
The amount of drainage was 155 ml (+/-<DS) in the control group and 72.73 (+/-<DS) in the TXA group (P=0.042). No patient received a transfusion and four complications were observed. One postoperative seroma resolved with ice and compression. The other three were considered not related to the procedure or the intervention.
Discussion
In this cohort of patients, those who received TXA after RSA experienced significantly less blood loss and drain output. The elimination of drainage may be safe in RSA and may reduce postoperative care and associated costs.